CTOs on the Move

Long Island Internet Headquarters

www.lihq.com

 
Long Island Internet Headquarters is a Melville, NY-based company in the Software and Internet sector.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.lihq.com
  • 506 Walt Whitman Rd
    Melville, NY USA 11747
  • Phone: 631.393.7800

Executives

Name Title Contact Details

Similar Companies

Lucas-Benning Power

Lucas-Benning Power is a Dallas, TX-based company in the Software and Internet sector.

Element Blue

Element Blue is a leading provider of IBM’s Intelligent Operations Center (IOC), as well as IBM WebSphere Portal, IBM Business Process Manager platform, and IBM SmartCloud solutions. We create software products serving the Energy, Healthcare, Retail and Government markets. Element Blue has over 12 years of organizational history in creating value for business operations with innovative web and mobile applications.

BUFFERZONE Security

BUFFERZONEs advanced endpoint security solution features: • Container: A secure, virtual environment for accessing content from any potentially risky source including internet browsers, removable media and e-mail. • Bridge: A configurable process...

Collectively

Award-winning social influence agency. We offer campaign strategy, execution, and reporting for any influencer marketing need.

Kapost

Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.